title: P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.
abstract: BACKGROUND
  Metastatic melanoma represents a major clinical problem. Its incidence continues to rise in western countries and there are currently no curative treatments. While mutation of the P53 tumour suppressor gene is a common feature of many types of cancer, mutational inactivation of P53 in melanoma is uncommon; however, its function often appears abnormal.
  
  
  METHODS
  In this study whole genome bead arrays were used to examine the transcript expression of P53 target genes in extracts from 82 melanoma metastases and 6 melanoma cell lines, to provide a global assessment of aberrant P53 function. The expression of these genes was also examined in extracts derived from diploid human melanocytes and fibroblasts.
  
  
  RESULTS
  The results indicated that P53 target transcripts involved in apoptosis were under-expressed in melanoma metastases and melanoma cell lines, while those involved in the cell cycle were over-expressed in melanoma cell lines. There was little difference in the transcript expression of P53 target genes between cell lines with null/mutant P53 compared to those with wild-type P53, suggesting that altered expression in melanoma was not related to P53 status. Similarly, down-regulation of P53 by short-hairpin RNA (shRNA) had limited effect on P53 target gene expression in melanoma cells, whereas there were a large number of P53 target genes whose mRNA expression was significantly altered by P53 inhibition in melanocytes. Analysis of whole genome gene expression profiles indicated that the ability of P53 to regulate genes involved in the cell cycle was significantly reduced in melanoma cells. Moreover, inhibition of P53 in melanocytes induced changes in gene expression profiles that were characteristic of melanoma cells and resulted in increased proliferation. Conversely, knockdown of P53 in melanoma cells resulted in decreased proliferation.
  
  
  CONCLUSIONS
  These results indicate that P53 target genes involved in apoptosis and cell cycle regulation are aberrantly expressed in melanoma and that this aberrant functional activity of P53 may contribute to the proliferation of melanoma.
authors: Oncology and Immunology, Calvary Mater Newcastle Hospital, University of Newcastle, Newcastle, NSW, Australia.
authors: Kelly A
authors: KA
authors: Avery-Kiejda
authors: Nikola A
authors: NA
authors: Bowden
authors: Amanda J
authors: AJ
authors: Croft
authors: Lyndee L
authors: LL
authors: Scurr
authors: Carla F
authors: CF
authors: Kairupan
authors: Katie A
authors: KA
authors: Ashton
authors: Bente A
authors: BA
authors: Talseth-Palmer
authors: Helen
authors: H
authors: Rizos
authors: Xu D
authors: XD
authors: Zhang
authors: Rodney J
authors: RJ
authors: Scott
authors: Peter
authors: P
authors: Hersey
references: Gene Ther. 2000 Jun;7(11):910-3
references: 10849549
references: BMC Cancer. 2005 Apr 08;5:36
references: 15819981
references: Melanoma Res. 1995 Apr;5(2):93-100
references: 7620345
references: Cancer Res. 2005 Mar 15;65(6):2260-8
references: 15781639
references: Oncogene. 2001 Jun 7;20(26):3341-7
references: 11423984
references: Pigment Cell Melanoma Res. 2010 Dec;23(6):781-94
references: 20849464
references: Cell Cycle. 2007 May 2;6(9):1006-10
references: 17457049
references: Oncogene. 2005 Apr 18;24(17):2899-908
references: 15838523
references: J Biol Chem. 2004 Jul 23;279(30):31251-8
references: 15159397
references: Cancer Res. 1996 Feb 15;56(4):892-8
references: 8631030
references: Nat Rev Cancer. 2002 Aug;2(8):594-604
references: 12154352
references: J Dermatol Sci. 2006 Jan;41(1):31-41
references: 16289694
references: J Natl Cancer Inst. 2002 Dec 4;94(23):1803-6
references: 12464652
references: N Engl J Med. 2004 Sep 2;351(10):998-1012
references: 15342808
references: EMBO J. 2003 Jun 2;22(11):2860-71
references: 12773400
references: Clin Cancer Res. 2007 Oct 15;13(20):5991-4
references: 17947459
references: Cancer Cell. 2007 Nov;12(5):414-8
references: 17996645
references: Cell Death Differ. 2008 Jun;15(6):959-76
references: 18356920
references: Cell Growth Differ. 2000 Sep;11(9):467-74
references: 11007451
references: Nat Med. 1996 Jan;2(1):72-9
references: 8564846
references: J Virol. 1998 Nov;72(11):8463-71
references: 9765382
references: Cell Death Differ. 2007 Jan;14(1):3-9
references: 17068503
references: Oncogene. 2003 May 19;22(20):3138-51
references: 12789290
references: Biochem Biophys Res Commun. 2005 Jun 10;331(3):851-8
references: 15865941
references: Br J Cancer. 1999 Feb;79(5-6):921-6
references: 10070891
references: Oncogene. 2003 May 19;22(20):3092-8
references: 12789286
references: Oncogene. 2005 Aug 11;24(34):5299-312
references: 15940268
references: Nat Rev Cancer. 2004 Oct;4(10):793-805
references: 15510160
references: Int J Cancer. 1994 Oct 15;59(2):191-5
references: 7927918
references: Am J Pathol. 2009 Jun;174(6):2367-77
references: 19389934
references: Nature. 2006 Nov 30;444(7119):629-32
references: 17108971
references: Cancer Res. 1999 Jun 1;59(11):2747-53
references: 10364001
references: Cell. 2005 Nov 18;123(4):641-53
references: 16286009
references: J Cell Sci. 2006 Dec 15;119(Pt 24):5015-20
references: 17158908
references: Carcinogenesis. 2008 Jan;29(1):194-201
references: 17916908
references: Lancet. 2005 Feb 19-25;365(9460):687-701
references: 15721476
references: Br J Cancer. 2007 Nov 5;97(9):1225-33
references: 17968428
references: Clin Cancer Res. 2008 Mar 15;14(6):1659-68
references: 18310316
references: Int J Oncol. 2009 Jan;34(1):5-13
references: 19082472
references: Nucleic Acids Res. 2002 Jun 1;30(11):2398-406
references: 12034827
references: Cancer Res. 1995 Apr 15;55(8):1649-54
references: 7712469
references: Pathology. 2006 Aug;38(4):287-301
references: 16916716
references: Oncogene. 2003 Jul 31;22(31):4911-7
references: 12894234
references: Biochem Biophys Res Commun. 2007 Dec 28;364(4):978-84
references: 17971299
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Cell. 2004 Feb 20;116(4):499-509
references: 14980218
references: J Clin Invest. 1999 Aug;104(3):263-9
references: 10430607
references: Cell Death Differ. 2006 Jun;13(6):951-61
references: 16575405
references: Pigment Cell Melanoma Res. 2010 Dec;23(6):771-80
references: 20718941
references: Cell. 2006 Jan 13;124(1):207-19
references: 16413492
references: Nat Cell Biol. 2009 Sep;11(9):1135-42
references: 19701195
references: Nat Rev Cancer. 2001 Dec;1(3):233-40
references: 11902578
references: Int J Cancer. 2006 Feb 1;118(3):577-82
references: 16094622
references: Nat Med. 2005 Dec;11(12):1306-13
references: 16286925
references: Science. 2002 Apr 19;296(5567):550-3
references: 11910072
references: Int J Cancer. 2007 May 15;120(10):2110-8
references: 17266041